IL-2 R beta Antibody (TM-b1) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-53132
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Block/Neutralize, CyTOF-ready, Flow Cytometry, Immunoprecipitation
Label
Unconjugated
Antibody Source
Monoclonal Rat IgG2B Clone # TM-b1
Format
Azide and BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
The immunogen for this antibody was Purified CD122.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2B
Scientific Data Images for IL-2 R beta Antibody (TM-b1) - Azide and BSA Free
Flow Cytometry: IL-2 R beta Antibody (TM-b1) - Azide and BSA Free [NBP2-53132]
Flow Cytometry: IL-2 R beta Antibody (TM-b1) - Azide Free [NBP2-53132] - Staining of C57Bl/6 splenocytes with Anti-Mouse NK1.1 APC and 0.25 ug of Rat IgG2b K Isotype Control Purified (left) or 0.5 ug of Anti-Mouse CD122 Purified (right) followed by Anti-Rat IgG Biotin and Streptavidin PE . Cells in the lymphocyte gate were useApplications for IL-2 R beta Antibody (TM-b1) - Azide and BSA Free
Application
Recommended Usage
Flow Cytometry
1:10 - 1:1000
Immunoprecipitation
1:10 - 1:500
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.2)
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: IL-2 R beta
Long Name
Interleukin 2 Receptor beta
Alternate Names
CD122, IL-15 R beta, IL-2Rb, IL2R beta, IL2RB
Gene Symbol
IL2RB
Additional IL-2 R beta Products
Product Documents for IL-2 R beta Antibody (TM-b1) - Azide and BSA Free
Product Specific Notices for IL-2 R beta Antibody (TM-b1) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...